Core Viewpoint - The company has recently acquired a patent for a type of elastic liquid cooling device for optical modules, but it has not yet achieved actual supply applications for all its patents [1] Group 1: Patent Information - The company holds three patents related to liquid cooling technology: an elastic liquid cooling device for optical modules, a floating cold plate, and an elastic liquid cooling device for pluggable optical modules [1] - Among these, the elastic liquid cooling device for pluggable optical modules has been authorized, while the other two patents have not yet received authorization [1] Group 2: Current Status of Applications - The authorized patent for the elastic liquid cooling device for pluggable optical modules is still undergoing internal reliability testing and has not yet been applied in actual supply [1]

Core Viewpoint - The company is focused on providing comprehensive thermal management solutions, including simulation, design, manufacturing, and testing services, with a current emphasis on customized thermal products [1] Group 1: Business Overview - The company offers a range of thermal products such as liquid cooling modules, liquid cooling plates, and air cooling modules, along with self-manufactured components like heat pipes and vapor chambers [1] - These thermal solutions are being applied in sectors such as edge computing servers and energy storage [1] Group 2: Revenue Insights - The revenue generated from the thermal management segment currently constitutes a relatively small proportion of the company's total revenue [1]

2025年第三次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：300709 证券简称：精研科技 公告编号：2025-070 江苏精研科技股份有限公司 （1）现场会议：2025 年 12 月 10 日下午 15:00。 （2）网络投票： 一、会议召开情况 本次会议采取现场表决与网络投票相结合的方式召开。 （一）会议召开时间 A.通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 12 月 10 日的交易时间，即 9:15—9:25，9:30—11:30 和 13:00—15:00； B.通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 12 月 10 日 9:15—15:00。 （二）现场会议召开地点：常州市钟楼经济开发区棕榈路 59 号，江苏精研 科技股份有限公司 A1 办公楼三楼会议室。 （三）会议召集人 江苏精研科技股份有限公司董事会。 （四）投票方式 本次股东会通过深圳证券交易所交易系统和互联网投票系统向社会公众股 股东提供网络形式的投票平台。 （五）会议主持人 本次会议由公司董事长王明喜先生主 ...

国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于江苏精研科技股份有限公司 2025 年第三次临时股东会的法律意见书 致：江苏精研科技股份有限公司 国浩律师（上海）事务所（以下简称"本所"）担任江苏精研科技股份有限 公司（以下称"公司"）之特聘法律顾问，根据《中华人民共和国公司法》（以 下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《深圳证券交易所创业板股票上市规则》、《上市公司股东会规则》（以下简称 "《股东会规则》"）、《深圳证券交易所上市公司股东会网络投票实施细则》 （以下简称"《网络投票实施细则》"）等法律、法规及《江苏精研科技股份有 限公司章程》（以下称"《公司章程》"）等有关规定，指派何佳欢律师、周烨 培律师出席并见证公司2025年第三次临时股东会（以下简称"本次股东会"）， 对本次股东会的召集、召开程序、出席人员资格、会议表决程序等事宜进行了审 查。 本所依据本法律意见书出具日之前已经发生或存在的事实及中国现行法律、 法规及规范性文件发表法律意见。 本所同意将本法律意见书作为公司本次股东会公告的法定文件，随公司其他 公告文件一并公告。 本所律师已经对 ...

证券代码：300709 证券简称：精研科技 公告编号：2025-069 江苏精研科技股份有限公司 关于特定股东减持计划期限届满的公告 股东史娟华保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 一、减持计划的实施进展情况 1、减持股份情况 | 股东名 | 减持方 | 股份来源 | 减持时间 | 减持均价 | 减持股数 | 减持比例 | | --- | --- | --- | --- | --- | --- | --- | | 称 | 式 | | | （元/股） | （股） | （%） | | | | 首次公开发行 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 集中竞 | 前发行的股份 | 2025 | 年 | 11 月 | 17 | 41.73 | 1,661,739 | 0.89 | | 史娟华 | 价 | 以及资本公积 | 日至 | 11 | 月 28 | 日 | | | | | | | ...

Core Viewpoint - Jingyan Technology (300709.SZ) announced plans to use up to 1.6 billion yuan of idle funds for entrusted wealth management, with the investment types including bank wealth management products and asset management plans [2] Group 1: Investment Details - The company and its subsidiaries will utilize a maximum of 1.6 billion yuan for entrusted wealth management, which can be rolled over within the specified limit [2] - The investment period is valid for 12 months from the date of approval by the shareholders' meeting [2] Group 2: Management and Compliance - The company has established a "Entrusted Wealth Management System" and will adhere to prudent investment principles [2] - Qualified professional wealth management institutions will be selected as trustees, focusing on those with good credit status, financial health, no negative integrity records, and strong profitability [2]

每经AI快讯，精研科技（SZ 300709，收盘价：40.84元）11月24日晚间发布公告称，公司第四届第十二 次董事会会议于2025年11月24日在江苏精研科技股份有限公司会议室召开。会议审议了《关于公司2026 年度预计日常关联交易的议案》等文件。 每经头条（nbdtoutiao）——大鹏工业战略配售"肥"了自家人！认购价9元，上市首日涨到118元，实控 人和亲哥哥凭配售一天浮盈2492万元 （记者 曾健辉） 2024年1至12月份，精研科技的营业收入构成为：消费电子行业占比75.49%，其他行业占比21.84%，其 他业务占比2.66%。 截至发稿，精研科技市值为76亿元。 ...

Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]

江苏精研科技股份有限公司 第四届董事会独立董事专门会议 2025 年第二次会议审核意见 独立董事： 周健 刘永宝 王普查 公司向关联方常州皓研智能科技有限公司销售产品、委托常州皓研智能科技 有限公司外协加工、向关联方常州创研投资咨询有限公司出租房屋是公司正常的 生产经营所需，具有必要性和合理性。关联交易双方按市场价格定价，交易遵循 公允的定价规则，公司将按日常经营关联交易履行必要的批准程序，该交易不会 对公司独立性产生影响，不存在损害公司和全体股东利益的情形。 因此，我们同意公司 2026 年度预计日常关联交易的事项，并同意将本议案 提交公司董事会审议。 （以下无正文） （此页无正文，为《江苏精研科技股份有限公司第四届董事会独立董事专门会议 2025 年第二次会议审核意见》之签署页） 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司 独立董事管理办法》、《深圳证券交易所创业板股票上市规则》、《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》以及《江苏精 研科技股份有限公司章程》、《江苏精研科技股份有限公司独立董事制度》等相 关法律法规、规章制度的规定，江苏精研科技股 ...

关于公司 2026 年度预计日常关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述 证券代码：300709 证券简称：精研科技 公告编号：2025-068 江苏精研科技股份有限公司 由于日常经营业务需要，江苏精研科技股份有限公司（以下简称"公司"） 及子公司预计2026年度将与关联方发生的日常关联交易总额不超过201万元，其 中，与常州创研投资咨询有限公司（以下简称"创研投资"）发生日常关联交易 不超过1万元；与常州皓研智能科技有限公司（以下简称"常州皓研"）发生日 常关联交易不超过200万元。关联交易主要内容包括出租房屋、销售产品、委托 外协加工。2025年度，公司预计与关联方发生日常关联交易总额为不超过人民币 611万元，2025年度截至10月31日实际发生的日常关联交易总金额为人民币2.42 万元（未经审计）。 本次日常关联交易预计事项已经公司 2025 年 11 月 24 日召开第四届董事会 第十二次会议审议，以 7 票同意、0 票反对、0 票弃权审议通过了《关于公司 2026 年度预计日常 ...